Insulet (PODD) Tops Q3 EPS by 34c; offers guidance

Insulet (NASDAQ: PODD) reported Q3 EPS of $0.74, $0.34 better than the analyst estimate of $0.40. Revenue for the quarter came in at $432.7 million versus the consensus estimate of $414.32 million.

For the year ending December 31, 2023, the Company is raising its expected revenue growth to a range of 26% to 27% (previously 22% to 25%).

For earnings history and earnings-related data on Insulet (PODD) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk
• HP Inc. projects mid-single-digit PC market decline in 2027